Marinus Pharmaceuticals to Present at the RBC Capital Markets 2024 Global Healthcare ConferenceBusiness Wire • 4 days agoMarinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that Scott Braunstein, M.D...